The SLEEP meeting is the world’s premier forum on sleep medicine, and sleep and circadian research with attendees from around the world.
Dr Michael Thorpy: Shared Decision-Making Is Important for Managing Narcolepsy
Personalizing treatment for narcolepsy requires shared decision-making between patients and clinicians to understand the most important symptoms that need to be treated and the right therapy, said Michael Thorpy, MD, director of the Sleep-Wake Disorders Center at Montefiore Medical Center and professor of neurology at Albert Einstein College of Medicine.
Dr Cinthya Pena Orbea Discusses Socioeconomic Impacts on Sleep-Disordered Breathing
Many socioeconomic factors, such as neighborhood factors, access to care, and education can influence sleep, explained Cinthya Pena Orbea, MD, assistant professor of medicine, Cleveland Clinic.
Dr Michael Thorpy Explains Findings From REST-ON Trial for Narcolepsy Treatment
Once-nightly sodium oxybate was associated with a statistically significant reduction in cataplexy episodes among patients with narcolepsy, explained Michael Thorpy, MD, director of the Sleep-Wake Disorders Center at Montefiore Medical Center and professor of neurology at Albert Einstein College of Medicine.
The Challenges of Living With Narcolepsy While Pregnant and How Providers Can Help
A panel of providers and patients with narcolepsy who are parents shared the struggles and possible support tools that neurologists and other providers should be aware of when caring for patients with narcolepsy who are pregnant or postpartum.
Idiopathic Hypersomnia Needs More Attention to Overcome Challenges Regarding Diagnosis and Treatment
During her presentation at SLEEP 2022, Isabelle Arnulf, MD, PhD, a neurologist and professor, detailed the long list of challenges for understanding different aspects of idiopathic hypersomnia and called for more attention to be devoted to future research.
Dr Sean Drummond Discusses Pros, Cons of Consumer Sleep Technology
While consumer wearables for sleep are popular, evidence-based guidelines need to be established to interpret data coming from these technologies, said Sean Drummond, PhD, professor of clinical neuroscience, Turner Institute for Brain and Mental Health at Monash University.
Researchers Share Data on the Relationship Between Sleep Disorders and Depression, Suicide
Presenters from SLEEP 2022 contextualized some of the recent research showing the impact of sleep disorders on aspects of mental health, including depressive symptoms and suicide.
Rhinomed’s Michael Johnson Highlights 2022 Sleep and Snoring Report Findings
Michael Johnson, CEO of Rhinomed, expands on the findings of the 2022 Annual Global Sleep and Snoring Report conducted in February 2022, which found that people are not getting nearly as much sleep as they should.
Dr Stacey Simon Explains Effects of Type 1 Diabetes on Sleep
Behavioral and physiological components of type 1 diabetes and its management can contribute to worsened sleep and health outcomes, which can vary by age, according to Stacey Simon, PhD, sleep psychologist and associate professor, University of Colorado Denver, Children's Hospital Colorado.
In Keynote Address, Dr Susan Redline Refutes Report Claiming CPAP May Not Improve Health Outcomes
Susan Redline, MD, MPH, the SLEEP 2022 meeting keynote speaker, catalogued the evidence proving that continuous positive airway pressure (CPAP) does improve health outcomes—refuting a recent controversial report that claims otherwise.
Dr John Winkelman Emphasizes Importance of Long-term Research on Opioids for Restless Leg Syndrome
Opioids have been used for hundreds of years to treat restless leg syndrome (RLS), but there is currently a registry to understand the long-term effectiveness of opioids to treat RLS , said John Winkelman, MD, PhD, medical director, sleep disorders clinical research program, Massachusetts General Hospital.
Race Is Not a Risk Factor for Disrupted Sleep, but Racism Is
A panel of experts at the SLEEP 2022 conference argued against considering race a risk factor for health complications and disrupted sleep, saying that being on the receiving end of racial discrimination is the true risk factor.
Abstracts Highlight Association Between Idiopathic Hypersomnia and Weight, Social Relationships
Posters from the SLEEP 2022 conference revealed some of the interaction between idiopathic hypersomnia and different aspects of life, including weight changes and interpersonal relationships.
Dr Susan Redline Previews Her Keynote Address at SLEEP 2022
Susan Redline, MD, MPH, professor of sleep medicine and epidemiology, Harvard T.H. Chan School of Public Health, gives a preview of her SLEEP 2022 keynote and discusses her 30 years of sleep epidemiology advocacy.
SLEEP 2022 to Focus on Treatment Advancements, Timely Topics
From discussions on policies of time change to the neurobiology of narcolepsy, sessions at the SLEEP 2022 conference taking place June 4-8 will span a broad range of topics.
Dr Michael Thorpy Discusses the Efficacy of Solriamfetol on EDS Associated With Narcolepsy
Michael Thorpy, MD, director, Sleep-Wake Disorders Center, Montefiore Medical Center, and professor of neurology, Albert Einstein College of Medicine, speaks on the efficacy of solriamfetol observed in patients with excessive daytime sleepiness associated with narcolepsy, and which patient groups may best benefit from this therapy.
SLEEP 2021 Tech Roundup: Smartphones, Artificial Intelligence, and More
A roundup of technology-related research presented at SLEEP 2021.
Sex Differences in AUD-Related Sleep Health Outcomes
Experts discuss their research on the impact of sex differences in alcohol use disorder (AUD)-related sleep health.
IHSS Proves Effective at Measuring IH Symptoms
Results of a post-hoc analysis underscore the efficacy of the Idiopathic Hypersomnia Severity Scale to measure symptoms of idiopathic hypersomia.
How Did COVID-19 Impact Adolescent Sleep Health?
Several studies presented at SLEEP 2021 highlight the negative impact COVID-19 has had on youth sleep health.
Dr Anne Marie Morse Addresses Screening for OSA in Patients With Stroke
Anne Marie Morse, DO, pediatric neurologist and sleep medicine specialist, Geisinger, discusses factors contributing to insufficient screening of obstructive sleep apnea (OSA) in patients with stroke and how a team-based approach fared in expediting diagnosis.
Understanding the Role of Sleep in Safety-Sensitive Occupations
Research presented at SLEEP 2021 underscores the important role of sleep for firefighters, soldiers, and flight crew members.
Rajasi Mills Explains Smart Bed Applicability in Measuring Sleep Metrics, Identifying Symptoms for COVID-19
Rajasi Mills, MS, vice president, SleepIQ Health, Sleep Number, speaks on the practical use of Sleep Number 360 smart beds in measuring sleep metrics and leveraging data to identify symptoms characteristic of COVID-19 and other respiratory illnesses.
Dr Isabelle Arnulf Highlights Efficacy, Safety of Lower-Sodium Oxybate in Idiopathic Hypersomnia
Isabelle Arnulf, MD, PhD, senior neurologist, and professor, Neurology, Sorbonne Universités, Pierre and Marie Curie University, discusses findings of significant improvement observed in patients with idiopathic hypersomnia undergoing lower-sodium oxybate treatment.
Dr Katharine Simon on Contributors to Autonomic Dysfunction, Implications for Sleep and Health
Katharine Simon, PhD, clinical pediatric psychologist, and postdoctoral researcher, Sleep and Cognition Lab, UC Irvine, explains the influence of the autonomic nervous system on body functions and recommendations for patients experiencing autonomic imbalance and sleep dysregulation.
Session Addresses Environmental, Social Determinants of Sleep Health
A session presented at Virtual SLEEP 2021 highlights the social and environmental factors that impact sleep health.
Dr Shalini Paruthi Discusses Clinical Implications of Diagnosis, Evaluation for Common Sleep Disorders
Shalini Paruthi, MD, medical codirector, St. Luke’s Hospital, Sleep Medicine and Research Center, and cochair of SLEEP 2021, highlights discussion topics that will address best practices for evaluating, diagnosing, and treating common sleep disorders.
Dr Michael Thorpy on Mechanisms, Applicability of the Idiopathic Hypersomnia Severity Scale
Michael Thorpy, MD, director of the Sleep-Wake Disorders Center, Montefiore, and professor of neurology, Albert Einstein College of Medicine, discusses aspects of the Idiopathic Hypersomnia Severity Scale, and how it fared in measuring symptoms of idiopathic hypersomnia compared with traditional scales.
Assessing HEOR in Patients With Central Disorders of Hypersomnolence
Abstracts presented at SLEEP 2021 include real-world data characterizing individuals with central disorders of hypersomnolence.
Dr Rebecca Spencer on Potential Takeaways, Topics of Interest at SLEEP 2021
Rebecca Spencer, PhD, professor, Department of Psychological and Brain Sciences, University of Massachusetts Amherst, and co-chair of SLEEP 2021, highlights takeaways from this year’s meeting and discussions she’s looking forward to.
2 Clarke Drive Cranbury, NJ 08512